ARS Pharmaceuticals, Inc.
SPRYPharmaceutical Preparations · SIC 2834 · CIK 0001671858
Revenue FY2025
$84.0M
Net Income
$(171.0M)
EPS (Basic)
$-1.74
Net Margin
-203.3%
ROE
-149.9%
Total Equity
$114.0M
Shares Out
99M
ARS Pharmaceuticals, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2020–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 6 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
RA Capital Management
RA Capital Management
$87.0M
0.5%
—
OrbiMed Advisors
OrbiMed Advisors
$66.4M
0.3%
—
Deerfield Management Company
Deerfield Management Company
$60.1M
0.3%
—
Third Point
Daniel Loeb
$8.0M
0.0%
—
Royce & Associates
Royce & Associates
$0.4M
0.0%
—
Capital World Investors
Capital World Investors
$22.1M
0.0%
NEW
Insider Transactions
Reading stored insider transactions…